Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Anticancer activity seen with ARQ-197 in phase I metastatic cancer trial

Nov. 12, 2007

131I-TM-601 crosses blood-brain barrier in glioma patients

Nov. 12, 2007

First-in-man study of tafluposide determines MTD in cancer patients

Nov. 12, 2007

Poniard reports positive preliminary data from ongoing phase I trial of oral picoplatin

Nov. 9, 2007

Novacea ends ASCENT-2 trial of Asentar for androgen-independent prostate cancer

Nov. 9, 2007

MDV-3100 demonstrates reductions in prostate-specific antigen in phase I/II trial

Nov. 9, 2007

Exelixis has numerous poster presentations at AACR-NCI-EORTC conference

Nov. 9, 2007

Sunesis Pharmaceuticals reports recent data on two lead compounds

Nov. 9, 2007

FDA approves Epeius's phase II registration protocol of Rexin-G for osteosarcoma

Nov. 8, 2007

Recent patents cover new therapeutic agents for cancer

Nov. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....